Table 1 |
|||
|
Characteristics of patients |
|||
|
Lupus matched (n = 45) |
Normal control (n = 45) |
Lupus unmatched (n = 62) |
|
|
|
|||
|
Age (years) |
40.47 ± 15.5 |
41.38 ± 15.9 |
37.27 ± 13.02 |
|
Sex (F:M) |
34:11 |
34:11 |
51:11 |
|
Ethnicity |
|||
|
Caucasian |
41 |
41 |
54 |
|
African |
2 |
2 |
2 |
|
Asian |
1 |
1 |
3 |
|
American Indian |
1 |
1 |
3 |
|
ACR total |
5.51 ± 1.69 |
5.53 ± 1.72 |
|
|
Anti-dsDNA Ab (%) |
33.3 |
22.6 |
|
|
Anti-Sm Ab (%) |
28.9 |
12.5 |
|
|
Anti-Ro (SSA) Ab (%) |
42.2 |
35.5 |
|
|
Anti-La (SSB) Ab (%) |
8.9 |
22.6 |
|
|
Anticardiolipin Ab (%) |
48.8 |
35.7 |
|
|
Lupus anticoagulant (%) |
15.6 |
11.7 |
|
|
Anti-B2 glycoprotein Ab (%) |
11.1 |
14.5 |
|
|
APS (%) |
37.8 |
14.8 |
|
|
Decreased C3 (%) |
8.9 |
4.8 |
|
|
Decreased C4 (%) |
42.2 |
30.7 |
|
|
SLEDAI |
6.02 ± 4.3 |
4.75 ± 4.08 |
|
|
BILAG |
6.93 ± 5.34 |
5.59 ± 3.73 |
|
|
|
|||
|
Ab, antibody; ACR total, the number of American College of Rheumatology 1982 revised criteria for classification of systemic lupus erythematosus; APS, antiphospholipid syndrome; BILAG, British Isles Lupus Assessment Group; F, female; M, male; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index. |
|||
|
Suh et al. Arthritis Research & Therapy 2010 12:R146 doi:10.1186/ar3088 |
|||
